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ADVERSE DRUG EVENTS AND ELECTRONIC MEDICAL RECORDS: RESULTS FROM
THE 2007-2008 NATIONAL AMBULATORY MEDICAL CARE SURVEY
Hogg JM, Heaton PC
University of Cincinnati, Cincinnati, OH, USA
OBJECTIVES: The goal of this study was to evaluate the impact of electronic medical
record (EMR) use on the frequency of visits due to an adverse event as reported in the
National Ambulatory Medical Care Survey (NAMCS) 2007-2008 database. The specific
objective was to determine the frequency of adverse events in patient visits that in-
cluded the use of an EMR compared to visits without the use of an EMR. An adverse
event was defined as an adverse outcome frommedical or surgical care or an adverse
drug event.METHODS: The study design was a retrospective, cross-sectional, obser-
vational analysis of the NAMCS database from 2007-2008. Patient visits that were the
result of an adverse event were selected from all established patient visits. The fre-
quencyofadverseeventswasanalyzedwith respect to theuseofanEMR.Patientvisits
were weighted with a statistical multiplier to generate national estimates. RESULTS:
Anadverse event occurred in 44,035,493 (2.6%) patient visits. Of these visits, 26,067,600
(1.5%) did not include the use of an EMR, while 17,967,893 (1.1%) included use of an
EMR. The majority of visits including the use of an EMR were by female patients
(59.4%), white patients (83.2%), or patients age 45-64 years (29.2%). Only 40.2% of es-
tablished patient visits included the use of an EMR. CONCLUSIONS: Adverse event
frequencywas lower inpatientvisits thatutilizedanEMRascompared topatientvisits
that did not include the use of an EMR. Increasing EMR use will allow healthcare
professionals to further prevent adverse events.
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STATUS OF PHARMACIST AT COMMUNITY LEVEL: AN EXPLORATORY STUDY
IN QUETTA, PAKISTAN
Saleem F1, Al-Qazaz HK1, Azhar S1, Ahmad N1, Atif M1, Haq N1, Asif M2, Iqbal Q3
1Universiti Sains Malaysia (USM), Pinang, Penang, Malaysia, 2The Islamia University of
Bahawalpur, Bahawalpur, Punjab, Pakistan, 3University of Balochistan, Quetta, Balochistan,
Pakistan
OBJECTIVES: To study the status of pharmacists working at community pharma-
cies in Quetta city, Pakistan.METHODS: A cross-sectional survey was designed to
conduct this study. A questionnaire about status of pharmacists working at com-
munity pharmacies was constructed, content validated and used. Pharmacists
were hired for data collection and analyses were done by SPSS 15. RESULTS:All 415
community pharmacies of the city were approached and 392 responded (94.45%).
Major respondents (81.25%) did not possess the basic requirement of Pharmacy
degree although the community pharmacies were licensed under a qualified per-
son. There were only 18.75% pharmacies were a qualified pharmacist possessing
pharmacy degree was present. People with higher secondary education (31.25%)
were foundmostly involved in running community pharmacies. The knowledge of
medicines and generics was quite high (74.95%). Drug guides (45.25%) and informa-
tion given by medical sales representatives (30.25%) played a key role in the gen-
eration of this information. It was also reported by 65.50% that as business is less
profitable, pharmacies cannot afford a full time pharmacist where as 41.50% de-
scribed unemployment/lack of opportunities in other sectors, the reason of run-
ning a community pharmacy. 61.25%of the respondents had an experience ofmore
than 5 years working at community pharmacies. All pharmacies sold packedmed-
ications and dispensing was not done on any of the community pharmacy.
CONCLUSIONS: Pharmacist at the community level is important to minimize drug
use problems. There must be strict monitoring by the concern departments and
license issuing authorities in order to promote propermedication practices at com-
munity levels. In addition, the presence of Pharmacist at pharmacies shall be de-
clared mandatory.
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UTILIZATION AND COST OF THE HEALTH PLAN - EFFECTS OF SPOUSAL
BEREAVEMENT
Reis Neto J1, Arantes ACL2
1CAPESESP/CAPESAUDE, Rio de Janeiro, RJ, Brazil, 2CASA DO CUIDAR, Sao Paulo, SP, Brazil
OBJECTIVES: To evaluate the effects of widowhood on the outpatient and hospital
health services used by beneficiaries of a private health care plan in Brazil.
METHODS: Cohort study of beneficiaries listed as married of the health plan in
the database of January 2007, consisting of 29,932 couples. In a follow-up period
of 36 months was verified the date of death of a spouse, this being the date of
entry into the study. After exclusion of one case, 487 had records of use and cost
of health care examined during 12 months before and after the death. The
covariables in the study were the type of procedure (consultations, tests and
admissions), sex and age (up to 59 years, 60-69, 70-79, 80 or more years). The
statistical analysis used the Student t test for paired observations and a confi-
dence interval of 95%. The significance level was set at p 0.05. RESULTS: Be-
tween the two periods, the average number of consultations increased from 3.77 to
4.66 (p0.001), tests from 16.88 to 23.16 (p0.001) and admissions from 0.18 to 0.30
(p  0.007). Regarding medical and hospital expenditures (direct costs), this in-
creased from U$ 1,246.69 to U$ 1,941.47 (p  0.001). In the segmented analysis by
age groups, variations in quantities and costs of visits and tests were statisti-
cally significant (p 0.05), differently of admissions (p 0.05). As for the evalu-
ation by gender, only the variations of themean number of admissions and total
cost were not significant (p 0.05). CONCLUSIONS: This study demonstrated the
increased use of health services and direct costs of medical and hospital appoint-
ments, tests and admissions after the loss of a spouse. Themourning should not be
overlooked from the perspective of management, may be a predictor of morbidity
and use of health plan.
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MIXED EVIDENCE FOR THE ”HEALTHY ADHERER EFFECT” IN A SAMPLE OF
22,070 ADULTS WITH CHRONIC DISEASE IN THE UNITED STATES
McHorney C, Gadkari A
Merck & Co., Inc, North Wales, PA, USA
OBJECTIVES: The “healthy adherer effect” posits that part of the association be-
tween non-adherence and suboptimal health outcomes is the possible confound-
ing effect of worse lifestyle behaviors of non-adherers. Our objectivewas to test the
“healthy adherer effect” among US adults with chronic disease. METHODS: We
conducted a cross-sectional survey of 22,070 adults with asthma, hypertension,
diabetes, hyperlipidemia, osteoporosis, GERD, depression, or anxiety from the Har-
ris Chronic Disease Panel. Respondents were classified into one of three mutually-
exclusive categories: (1) persisters (i.e., currently taking medication); (2) non-per-
sisters (i.e., discontinuedmedication in the past year); and (3) non-fulfillers (i.e., did
not obtain the first fill for a new prescription in the past year). Respondents also
completed items on life style behaviors: weight and height to derive BMI, smoking
status; alcohol use; physical exercise; seatbelt use; and receipt of an influenza
vaccination in the past year. Linear and logistic regression was used to model
individual lifestyle behaviors on self-reported adherence status controlling for de-
mographic characteristics. RESULTS: Multivariate regressions revealed no statis-
tically-significant associations between adherence status and BMI (continuous),
weekly-moderate exercise, weekly-vigorous exercise, binge drinking, and obesity
as defined by the BMI. Multivariate regressions revealed that non-persisters and
non-fulfillers were significantly less likely to report having a flu shot in the past
year (OR0.76 and 0.73, respectively). Compared to persisters, non-persisters were
more likely to be current smokers (OR1.19, p.0043) andwere less likely to always
use seat belts (OR0.80, p.0009). CONCLUSIONS: In this Internet sample of 22,070
adults with chronic disease, we found mixed evidence for a “healthy adherer ef-
fect.” Non-persisters and non-fulfillers differed from persisters on some, but not
all, lifestyle behaviors. Future research should link both adherence behaviors and
life-style behaviors to risk of mortality and hospitalization.
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MORTALITY AFTER SPOUSAL BEREAVEMENT IN BENEFICIARIES OF THE
HEALTH PLAN
Reis Neto J, Arantes ACL
CAPESESP/CAPESAUDE, Rio de Janeiro, RJ, Brazil
OBJECTIVES: To evaluate the mortality rate in beneficiaries of a health plan in
Brazil after spouse death, compared with the expected in the population.
METHODS: Cohort study of beneficiaries of the health plan listed as married in
2007, consisting of 29,932 couples. Thereafter began a follow-up of 36 months for
verification of death of either spouse. During this period, entered the study at the
date of death of spouse, 308 widows and 180 widows. The mortality rate observed
in the groupwas comparedwith expectedmortality for the population of reference,
according to sex and age. Statistical analysis was considered the Standard Mortal-
ity Ratio (SMR), with evaluation of significance by the method of Poisson approxi-
mation with Byar and the Fisher exact test, with an confidence interval of 95%. The
significance level was set at p0.05. RESULTS: The mean age for males was 65.24
years (95% CI 51.03 to 79.45) and 63.91 years for females (95% CI 53.15 to 80.67).
Observed in period 35 deaths in the group (7.17%). In the first 12 months after
bereavement, mortality was 12 for an expected 6.15, SMR to 1.95 (p  0.0477). The
SMR in 24 months was 2.02 (p  0.0026) and at 36 months of 1.85 (p  0.0018).
CONCLUSIONS: This study showed higher than expected mortality to significant
levels in people who have experienced the death of a spouse.Measures to support
and healthcare for families who lives grief can be an interesting alternative in the
social aspect and somehow contribute to reducing the risk of mortality at the
expected level for sex and age.
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INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES
IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008
Liu Y1, Cai J2, Hong L3, Hoff GL2, Okah FA1
1The University of Missouri – Kansas City, Kansas City, MO, USA, 2Kansas City Health
Department, Kansas City, MO, USA, 3The University of Tennessee, Memphis, TN, USA
OBJECTIVES: 1) To describe the trends of unintentional fatal poisonings by noxious
substances in Kansas City, Missouri, from 1999 to 2008 and 2) to identify demo-
graphic risk factors associated with unintentional fatal poisonings. METHODS:
This was a retrospective study using the death data for Kansas City, Missouri. The
data included the cause of death, sex, race, age, annual income, and Health Zone
for each individual. Unintentional fatal poisonings by noxious substances were
identified by ICD-10 codes X40-X49. Age-adjusted death rates and age-specific
death rates of fatal poisonings were calculated for every year. Chi-square tests
were used to compare death rates for each demographic variable. Amultiple logis-
tic regression analysis was conducted to measure the odds ratio (OR) of fatal poi-
sonings due to sex, age, annual income, and Health Zone. RESULTS: Out of 38,785
deaths from all causes, 473 (1.2%) were identified to be due to unintentional fatal
poisonings. Age-adjusted death rates from unintentional fatal poisonings in-
creased from 7 per 100,000 population in 1999 to 14 in 2008, while the all-cause
age-adjusted death rates declined from 1999 to 2008. From 1999 to 2003, the age
group 35-44 years old had the highest death rate of unintentional fatal poisonings,
whereas from year 2004 to 2008, the age group 45-54 years old had the highest
death rate. In the logistic regression, compared with the age group of 55 years and
older, the age group of 35-44 years old had anOR of 44.06, and the age group of 45-54
years old had an OR of 21.49. There were differences in ORs by sex, annual income,
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and Health Zone. CONCLUSIONS: Age-adjusted death rates of unintentional fatal
poisonings increased for Kansas City, Missouri, from 1999 to 2008. Sex, age, annual
income, and Health Zone, were risk factors for unintentional fatal poisonings.
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A RAPID EVALUATION UNIT INCREASES EMERGENCY DEPARTMENT VISITS
Twanmoh J1, Fleming AE2, Brooks D3, Jiang Y4, Villacorta R4, McCombs J4
1St. Agnes Hospital, Baltimore, MD, USA, 2Johns Hopkins University, Baltimore, MD, USA, 3Johns
Hopkins Medicine, Baltimore, MD, USA, 4USC School of Pharmacy, Los Angeles, CA, USA
OBJECTIVES: Emergency Department [ED] overcrowding is a national problem.
This study evaluates the effect of a provider/nurse triage model (Rapid Evaluation
Unit, REU) designed to improve the efficiency of the ED on ED patient volume and
ambulance diversionhours.METHODS:Data ondaily patient counts [inpatient, ED]
and ambulance diversion hours for a single hospital in Baltimore were used to
evaluate the impact of REU on hospital performance. Data covered 2008, the year
before the REU was implemented, and 2009 during which the REU was imple-
mented incrementally. The REU was operating on Monday-Wednesday from Jan-
uary 1st through March 31st, and then Monday through Friday from April 1st
through December 31st. Regression models were estimated for the daily counts for
admissions, ED visits and ambulance diversion days controlling for time trend
effects, day of the week and month of the year. A spline functional form was used
to test the effects of the REU on pre-2009 time trends and to improve model fit.
Models were adjusted for autocorrelation and heteroskedasticity as needed.
RESULTS: The REU significantly increased ED patient visit counts by 5.5 visits per
day [p0.01] without increasing the number of hours the hospital was diverting
ambulances due to over crowding [0.83 hours per day, p0.05]. For ED visits, all
months exhibited significantly higher daily ED visit counts than inDecember, rang-
ing from 9 to 28 visits per day. The early work week [Monday-Wednesday] also
exhibited significantly higher rates of ED visits than Saturday [range: 5-12 visits per
day].CONCLUSIONS:The REUwas effective at increasing ED visitswithout increas-
ing ambulance diversion hours. We theorize that this may be due to a reduction in
the time spent by patients waiting for treatment.
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THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION
WITH PATIENT COUNSELING AT HOSPITAL ADMISSION
Chen CC1, Huang YF1, Ho SW2, Lu SH2, Lin HY2, Liu HP1
1Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan, 2Taipei Medical University,
Taipei, Taiwan
OBJECTIVES:Medication reconciliation is the process of obtaining andmaintaining
a complete and accurate list of the current medication therapy of a patient across
health care setting. The combination of recorded and reported (assessed through
patient counseling) medication use may increase the accuracy of medication rec-
onciliation process. The objective of this study is to prevent drug-related problems
and evaluate the effect of pharmacist-conducted medication reconciliation with
patient counseling at hospital admission.METHODS: Patients who were admitted
to Internal Medicine in local hospital, with age over 65 years, more than two co-
morbidities and receiving more than three regular medications were recruited.
Patients with cancer, admitted to the ICU, discharged within 48 hours, or unable to
communicate were excluded. Then, these patients were interviewed by pharma-
cists within 48 hours after admission. The unintentional discrepancies were dis-
cussed with the physicians and drug therapy would be adjusted accordingly. The
primary outcome of this study included the rate of unintentional discrepancies
identified by pharmacists before and after patient counseling and the rate of un-
reconciled medications resolved by pharmacists. RESULTS: Forty-nine patients
were recruited in this study and 129 unreconciledmedicationswere found between
October 17 and November 18, 2010. The most common type of discrepancies was
omissions with rate of 58.7%. On the other hand, the rate of unintentional discrep-
ancies identified by pharmacist which may cause harm increased from 6.6% to
12.4% after patients counseling and 81.3% of drug-related problem was resolved
after pharmacist intervention. Additionally, allergy history was established in
16.3% of patients. CONCLUSIONS: Pharmacist-conducted medication reconcilia-
tion with patient counseling improved drug therapy and completeness and accu-
racy of allergy history. However, this studywas only undertaken in patients admit-
ted to Internal Medicine during one month. Implementation of medication
reconciliationwith patient counseling to further patients, such as surgical patients
may be considered.
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THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN
DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY
ASSESSMENT IN POLAND (AHTAPOL)
Ofierska-Sujkowska G, Jagodzinska-Kalinowska K, Matusewicz W
Agency for Health Technology Assessment in Poland, Warsaw, Poland
OBJECTIVES: The aim of the present analysis was to identify what was the influ-
ence of prices and the corresponding low cost-effectiveness estimates of the ap-
praised orphan drugs on AHTAPol recommendations. The main task of AHTAPol,
established in 2005, is to assess and appraise all medical technologies and services
claiming publicmoney founding. Pharmacoeconomic evaluations of new therapies
are required for all reimbursement decisions and orphan drugmanufacturers can-
not be exempted from providing a full pharmacoeconomic or HTA reports. Recom-
mendations issued by AHTAPol have been based onManufacturer‘s submission,
additional officially published data, experts opinions and Polish public payer
(National Health Fund) evaluation.METHODS: All recommendations issued by the
AHTAPol until the end of 2010 were reviewed and analyzed from the official Web site
ofAHTAPol. Theorphandrugs recommendationswere identifiedand categorized into
types of recommendations (positive or negative) and reasoned. RESULTS:Among 286
AHTAPol decisions studied, 26 (9%) applied to orphan drugs. AHTAPol gave positive
recommendations for reimbursement to 19 of 26 of orphan drug submissions (73%). 7
(27%) were not approved and received negative recommendations. Only in one case
cost-effectiveness estimates and the corresponding high priceswere emphasized as a
main reason of negative recommendations. In 1 case the reason was connected
with drug safety issues, while in 5 cases with insufficient evidence of efficacy.
CONCLUSIONS:Thecost-effectiveness issues of theappraisedorphandrugswerenot
important argument in negative recommendations of the AHTAPol. In fact the insuf-
ficient evidence of clinical efficacy were the most important and therefore prevailing
argument for issuing negative opinions of AHTAPol recommendations.
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DEMONSTRATING CLINICAL-EFFECTIVENESS USING INDIRECT AND MIXED
TREATMENT COMPARISON ANALYSIS: A REVIEW OF MANUFACTURERS’
SINGLE TECHNOLOGY APPRAISAL (STA) SUBMISSIONS TO THE NATIONAL
INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Bending MW1, Hutton J1, McGrath C2
1University of York, York Health Economics Consortium, York, UK, 2Pfizer, Surrey, UK
OBJECTIVES: Indirect and Mixed Treatment Comparisons (ITC/MTC) can provide
valuable information for decision-makers, especially when direct comparisons be-
tween medicines are unavailable. The objective of this study is to investigate the
methods and impact of ITC and MTC submitted by manufacturers on the NICE
committee’s appraisal of pharmaceuticals. METHODS: A search of the NICE web-
site was conducted for manufacturers’ submissions that reported to contain either
an ITC orMTC since 2006. Datawere extracted and analysed for the type of network
meta-analysis, number of trials, head-to-head trial evidence available, disease
area, treatment comparisons, study selection justification, sensitivity analysis of
trial selection and outcome(s). The impact was assessed by analysing information
on Evidence Review Group (ERG) review of evidence synthesis, Appraisal commit-
tee’s comments and final decision. RESULTS: The search identified 24 submissions
that included either a MTC or ITC. The issues most frequently raised by the ERG
were lack of reporting of trial characteristics, description of methods and quality
assessment of all trials included. The most frequent validity concerns were both
clinical and statistical heterogeneity between trials, inappropriate methods of
analysis, exclusion of relevant trials and sparse numbers of trials in the network.
The committee considered all evidence and reported the analysis to be plausible on
one occasion, stated concernswith the validity in 18 appraisals and did not directly
comment on 5 occasions. Fifty eight percent of appraisals including an MTC or ITC
resulted in a restricted decision. CONCLUSIONS: ITC and MTC analysis has pro-
vided additional useful information for NICE appraisals but there has been wide
variation in the reporting and validity of analysis performed. Reimbursement
agencies should establish guidelines for the conduct of ITC andMTC to reduce this
variation. The emerging ISPOR Good Research Practice guide on indirect treatment
comparisons will provide a basis for these.
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PATTERNS OF INSURANCE COVERAGE IN THE UNITED STATES: ANALYSIS OF
THE 2004-2007 MEDICAL EXPENDITURE PANEL SURVEYS (MEPS)
Berry E1, Kelton CM1, Heaton PC1, Guo JJ2, Fairbrother G3, Hanseman D2
1University of Cincinnati, Cincinnati, OH, USA, 2University of Cincinnati Medical Center,
Cincinnati, OH, USA, 3Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
OBJECTIVES: The objective was to understand the extent of the insurance-loss
problem in the United States over a four-year period (2004-2007) by (1) determining
the number (and proportion) of individuals who experienced loss in insurance
coverage and (2) for those who experienced gaps in coverage, determining the
average length of those periods of time when they were without coverage.
METHODS: This study was a retrospective, longitudinal data analysis using
monthly data from the 2004-05, 2005-06, and 2006-07 panels of the Medical Expen-
diture Panel Survey (MEPS). Individuals were categorized on the basis of continuity
of insurance coverage: a cohort of continuously insured individuals; a cohort of
continuously uninsured people; and a cohort of people who experienced gaps
(from one to 23 months) in coverage. The number and percent of individuals who
were in each group for each panel were calculated. A chi-square test was used to
determine if therewere differences in the distribution of health insurance patterns
between the panels, and ANOVA was used to determine if there were differences
between the average gap length over the years. RESULTS: Pooling across the three
panels, there were 157,641,235 (17.37%) individuals who experienced gaps in insur-
ance coverage, 82,826,100 (9.12%)whowere continuously uninsured for 24months,
and 616,864,391 (67.95%) who had continuous coverage over a two-year period. The
proportion of continuously uninsured rose from 8.73% in 2004-05 to 9.23% in 2006-
07. The average gap length was 8.56, 8.44, and 8.54months in 2004-05, 2005-06, and
2006-07 respectively. There were no significant differences across the panels in
either the distribution of insurance coverage patterns or between the average gap
lengths. CONCLUSIONS: Patterns in health insurance coverage have remained sta-
ble over the past several years. Examination of changing patterns of insurance
coverage will be important as health reform is introduced between now and 2014.
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THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR
INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF
HEALTH SERVICES IN ISRAEL
Greenberg D1, Wacht O1, Siebzehner MI2
1Ben-Gurion University of the Negev, Beer-Sheva, Israel, 2The Israeli Center for Technology
Assessment in Health Care, Tel Hashomer, Israel
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